Cardioprotective Mechanisms of Beta-Blockers in Myocardial Ischemia and Reperfusion: From Molecular Targets to Clinical Implications
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26209843 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Athina Nasoufidou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, 54642 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Cardiotonic Agents, Myocardial Ischemia, Myocardial Reperfusion Injury. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ischemic heart disease remains the leading cause of death despite substantial advances in diagnosis, revascularization therapies, and risk-factor control. Beta-adrenergic receptor blockers (Beta-Blockers, BBs), long used to control heart rate, blood pressure, and reduce arrhythmic risk, may also confer cardioprotection through mechanisms beyond hemodynamic unloading. This review integrates an extensive range of preclinical, translational, and clinical studies to present a comprehensive overview of the cardioprotective effects of BBs in the context of myocardial ischemia and reperfusion injury. Mechanistic domains include modulation of redox homeostasis, attenuation of inflammation and neutrophil activation, preservation of mitochondrial integrity and anti-apoptotic signaling, improvement of endothelial function, and stabilization of calcium handling. Third-generation compounds, carvedilol and nebivolol, demonstrate additional antioxidant and vasodilatory benefits compared with first- and second-generation agents; however, no consistent class-wide effect exists across most pathways. The evidence base remains fragmented, often derived from agent- or context-specific studies in heterogeneous populations, with uncertainty surrounding optimal timing of intervention. By bridging mechanistic understanding with clinical outcomes, this review highlights the importance of standardized assessment of BB effects, the development of personalized treatment approaches, and the pursuit of future research to address ongoing translational gaps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, 54642 Thessaloniki, Greece.
- Department of Emergency Medicine, Aristotle University of Thessaloniki, AHEPA General University Hospital of Thessaloniki, 54636 Thessaloniki, Greece.
- Department of Cardiology, Tzaneio General Hospital of Piraeus, 18536 Piraeus, Greece.
ORCID-Profile: Athina Nasoufidou, Marios G Bantidos, Barbara Fyntanidou, Panagiotis Stachteas, Alexandra Arvanitaki, Paschalis Karakasis, Marios Sagris, Nikolaos Fragakis, Efstratios Karagiannidis
Zitieren
APA
Nasoufidou, A., Bantidos, M. G., Fyntanidou, B., Kofos, C., Stachteas, P., Arvanitaki, A., Karakasis, P., Sagris, M., Kassimis, G., Fragakis, N., & Karagiannidis, E. (2025). Cardioprotective Mechanisms of Beta-Blockers in Myocardial Ischemia and Reperfusion: From Molecular Targets to Clinical Implications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26209843
Vancouver
Nasoufidou A, Bantidos MG, Fyntanidou B, Kofos C, Stachteas P, Arvanitaki A, et al. Cardioprotective Mechanisms of Beta-Blockers in Myocardial Ischemia and Reperfusion: From Molecular Targets to Clinical Implications. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26209843
BibTeX
@article{Nasoufidou2025,
author = {Nasoufidou, Athina and Bantidos, Marios G and Fyntanidou, Barbara and Kofos, Christos and Stachteas, Panagiotis and Arvanitaki, Alexandra and Karakasis, Paschalis and Sagris, Marios and Kassimis, George and Fragakis, Nikolaos and Karagiannidis, Efstratios},
title = {Cardioprotective Mechanisms of Beta-Blockers in Myocardial Ischemia and Reperfusion: From Molecular Targets to Clinical Implications},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26209843}
}
EUVIMED